365 related articles for article (PubMed ID: 15203870)
41. HLA class II polymorphisms in Tunisian patients with dilated cardiomyopathy.
Mahjoub S; Mehri S; Ghazouani E; Ouarda F; Boussada R; Zaroui A; Mechmeche R; Hammami M; Ben Arab S
Tissue Antigens; 2010 Jun; 75(6):679-83. PubMed ID: 20136773
[TBL] [Abstract][Full Text] [Related]
42. MHC2TA single nucleotide polymorphism and genetic risk for autoimmune adrenal insufficiency.
Ghaderi M; Gambelunghe G; Tortoioli C; Brozzetti A; Jatta K; Gharizadeh B; De Bellis A; Pecori Giraldi F; Terzolo M; Betterle C; Falorni A
J Clin Endocrinol Metab; 2006 Oct; 91(10):4107-11. PubMed ID: 16849401
[TBL] [Abstract][Full Text] [Related]
43. Association of HLA-DR and -DQ genes with narcolepsy in Koreans: comparison with two control groups, randomly selected subjects and DRB1*1501-DQB1*0602--positive subjects.
Roh EY; Park MH; Park H; Park DH; Choi JB; Kim SJ; Jeong DU
Hum Immunol; 2006 Sep; 67(9):749-55. PubMed ID: 17002906
[TBL] [Abstract][Full Text] [Related]
44. [Possible association between HLA-HRB1 and DQB1 genes frequency and susceptibility or resistance to Helicobacter pylori infection in Kunming Yi ethnic group children].
Huang YK; Wen GS; Li HL; Hao P; Qi Q; Zhou LF
Zhonghua Er Ke Za Zhi; 2005 Feb; 43(2):137-40. PubMed ID: 15833172
[TBL] [Abstract][Full Text] [Related]
45. HLA class II alleles and chronic hepatitis C virus infection.
Cangussu LOF; Teixeira R; Campos EF; Rampim GF; Mingoti SA; Martins-Filho OA; Gerbase-DeLima M
Scand J Immunol; 2011 Sep; 74(3):282-287. PubMed ID: 21535077
[TBL] [Abstract][Full Text] [Related]
46. HLA class II profile: a weak determinant of factor VIII inhibitor development in severe haemophilia A. UKHCDO Inhibitor Working Party.
Hay CR; Ollier W; Pepper L; Cumming A; Keeney S; Goodeve AC; Colvin BT; Hill FG; Preston FE; Peake IR
Thromb Haemost; 1997 Feb; 77(2):234-7. PubMed ID: 9157572
[TBL] [Abstract][Full Text] [Related]
47. Susceptible and protective major histocompatibility complex class II alleles in early-onset pauciarticular juvenile chronic arthritis.
Haas JP; Nevinny-Stickel C; Schoenwald U; Truckenbrodt H; Suschke J; Albert ED
Hum Immunol; 1994 Nov; 41(3):225-33. PubMed ID: 7868378
[TBL] [Abstract][Full Text] [Related]
48. The effect of HLA on immunological response to hepatitis B vaccine in healthy people: a meta-analysis.
Li ZK; Nie JJ; Li J; Zhuang H
Vaccine; 2013 Sep; 31(40):4355-61. PubMed ID: 23887040
[TBL] [Abstract][Full Text] [Related]
49. Human leukocyte antigen class II DQB1*0301, DRB1*1101 alleles and spontaneous clearance of hepatitis C virus infection: a meta-analysis.
Hong X; Yu RB; Sun NX; Wang B; Xu YC; Wu GL
World J Gastroenterol; 2005 Dec; 11(46):7302-7. PubMed ID: 16437632
[TBL] [Abstract][Full Text] [Related]
50. HLA class II alleles associated with infection by HPV16 in cervical cancer in situ.
Beskow AH; Josefsson AM; Gyllensten UB
Int J Cancer; 2001 Sep; 93(6):817-22. PubMed ID: 11519043
[TBL] [Abstract][Full Text] [Related]
51. The role of major histocompatibility complex alleles in the susceptibility of Brazilian patients to develop the myogenic type of Graves' orbitopathy.
Akaishi PM; Cruz AA; Silva FL; Rodrigues Mde L; Maciel LM; Donadi EA
Thyroid; 2008 Apr; 18(4):443-7. PubMed ID: 18352820
[TBL] [Abstract][Full Text] [Related]
52. Motif analysis of HLA class II molecules that determine the HPV associated risk of cervical carcinogenesis.
Odunsi K; Ganesan T
Int J Mol Med; 2001 Oct; 8(4):405-12. PubMed ID: 11562779
[TBL] [Abstract][Full Text] [Related]
53. The complexity of HLA class II (DRB1, DQB1, DM) associations with disseminated Mycobacterium avium complex infection among HIV-1-seropositive whites.
Naik E; LeBlanc S; Tang J; Jacobson LP; Kaslow RA
J Acquir Immune Defic Syndr; 2003 Jun; 33(2):140-5. PubMed ID: 12794545
[TBL] [Abstract][Full Text] [Related]
54. Human leukocyte antigens and genetic susceptibility to lymphoma.
McAulay KA; Jarrett RF
Tissue Antigens; 2015 Aug; 86(2):98-113. PubMed ID: 26189878
[TBL] [Abstract][Full Text] [Related]
55. HLA class II genotype influences the type of liver injury in drug-induced idiosyncratic liver disease.
Andrade RJ; Lucena MI; Alonso A; García-Cortes M; García-Ruiz E; Benitez R; Fernández MC; Pelaez G; Romero M; Corpas R; Durán JA; Jiménez M; Rodrigo L; Nogueras F; Martín-Vivaldi R; Navarro JM; Salmerón J; de la Cuesta FS; Hidalgo R
Hepatology; 2004 Jun; 39(6):1603-12. PubMed ID: 15185301
[TBL] [Abstract][Full Text] [Related]
56. Is HLA class II susceptibility to primary antiphospholipid syndrome different from susceptibility to secondary antiphospholipid syndrome?
Freitas MV; da Silva LM; Deghaide NH; Donadi EA; Louzada-Júnior P
Lupus; 2004; 13(2):125-31. PubMed ID: 14995006
[TBL] [Abstract][Full Text] [Related]
57. [HLA DRB1*, DQB1*, DPA1*, and DPB1* and their association with the pathogenesis of leukemia in the population of Venezuela].
Rivera-Pirela SE; Echeverría M; Salcedo P; Márquez G; Carrillo Z; Parra Y; Cipriani AM; Núñez JR; Álvarez de Mon M
Rev Alerg Mex; 2016; 63(3):237-51. PubMed ID: 27560912
[TBL] [Abstract][Full Text] [Related]
58. Variation in effects of non-Hodgkin lymphoma risk factors according to the human leukocyte antigen (HLA)-DRB1*01:01 allele and ancestral haplotype 8.1.
Wang SS; Lu Y; Rothman N; Abdou AM; Cerhan JR; De Roos A; Davis S; Severson RK; Cozen W; Chanock SJ; Bernstein L; Morton LM; Hartge P
PLoS One; 2011; 6(11):e26949. PubMed ID: 22096508
[TBL] [Abstract][Full Text] [Related]
59. Negative association of the HLA-DQB1*02 allele with breast cancer development among Jordanians.
Atoum MF; Tanashat RQ; Mahmoud SA
Asian Pac J Cancer Prev; 2013; 14(11):7007-10. PubMed ID: 24377640
[TBL] [Abstract][Full Text] [Related]
60. Decreased frequency of the HLA-DRB1*11 allele in patients with chronic hepatitis C virus infection.
Yenigün A; Durupinar B
J Virol; 2002 Feb; 76(4):1787-9. PubMed ID: 11799174
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
